COS-9 Current concepts III

Saturday, June 7
0800-1000
Room: 200 CD

Objectives
At the end of this session, participants will be able to:

  • Describe the evolution of surgical options for glaucoma patients
  • Apply newer strategies for the diagnosis and treatment of macular degeneration and Leber's optic neuropathy
  • Integrate a paradigm for managing corneal lacerations

Guests
Keith Barton, MD
M. Bowes Hamill, MD
Byron Lam, MD
Peter Lin, MD
Janey L. Wiggs, MD
Marco A. Zarbin, MD
 Moderators
Yvonne M. Buys
Arif Samad

Schedule and description
0800Introductions
Yvonne M Buys
0805Glaucoma surgery: past, present and future
Keith Barton
0815Discussion
0820A practical approach to the lacerated cornea
M. Bowes Hamil
0830Discussion
0835Genetics in the glaucoma clinic: Diagnostic testing and new ideas for treatment
Janey Wiggs
0845Discussion
0850New drug treatments for wet age-related macular degeneration
Marco A. Zarbin
0900Discussion
0905Leber hereditary optic neuropathy gene therapy
Byron Lam
0915Discussion
0920New treatments for dry AMD
Marco A. Zarbin
0930Discussion
0935COS lecture: In the era of generics - what does equal really mean?
Peter Lin
0955Discussion

Keith Barton
Keith Barton, MD

Bowes Hamill
M. Bowes Hamill, MD

Byron Lam
Byron Lam, MD

Peter Lin
Peter Lin, MD

Janey L. Wiggs
Janey L. Wiggs, MD

Marco A. Zarbin
Marco A. Zarbin, MD